U.S. Senator Charles E. Schumer has urged the United States Department of Agriculture (USDA) to hold off on implementing the U.S. Domestic Hemp Production Program final rule until 2022. Senator Schumer was a supporter of the Hemp Farming Act of 2018 and believed the crop should have the full backing...

The American Heart Association says marijuana should be removed from the USA's Schedule I controlled substance category - but not to encourage wider use. Not all cannabis is equal in the eyes of the law in the USA. Hemp and marijuana are both cannabis, but are treated very differently. The 2018...

Australia's Therapeutic Goods Administration (TGA) had a busy July in relation to approving applications for medicinal cannabis products. Australia's Special Access Scheme (SAS) enables suitably authorised health practitioners to access therapeutic products not included in the Australian Register of Therapeutic Goods (ARTG). The only cannabis product currently included in the...

Some doctors in Western Australian and their patients should have easier and faster access to medical cannabis resulting from a deal signed between Jupiter Health Clinics and Montu. Founded in 2011, Jupiter Health and Medical Services is a network of more than 300 doctors in 30 medical practices across...

Penn State College of Medicine researchers have found products containing cannabinoids may have impacts on the effects of some conventional prescription drugs. The researchers have put together a list of 57 medications that may not function as intended when used with cannabis products including medical cannabinoids, CBD oil and medical...

GW Pharmaceuticals has achieved one of its goals for this year - seeing Epidiolex approved for the treatment of seizures associated with tuberous sclerosis complex (TSC). The U.S. Food and Drug Administration announced approval of Epidiolex for TSC last Friday, a cannabidiol based medicine previously approved for treatment of seizures...

Western Australia's McGowan Government has awarded $300,000 to medical cannabis company Little Green Pharma (ASX:LGP). Little Green Pharma was the first Australian medicinal cannabis company to produce locally-grown medicines for patient use both here and for export markets. It's a vertically integrated business with operations ranging from cultivation and production...

The European Commission is poised to kill the EU's hemp sector claims the European Industrial Hemp Association (EIHA). It says the EC recently arrived at a preliminary conclusion that extracts from industrial hemp, which would include cannabidiol, qualify as drugs in EU legislation. This has thrown a spanner into the...

Research out of University of Newcastle in Australia indicates cannabis has the potential to kill or inhibit cancer cells without impacting normal cells. Cancer researcher Dr Matt Dun collaborated with Australian Natural Therapeutics Group (ANTG), which produces a variety of cannabis with high levels of cannabidiol (CBD) and low levels...

Well, this is getting a little over the top. Updated directives from the U.S. Navy powers-that-be state sailors and marines are prohibited from more products made or derived from hemp. Section 12619 of the 2018 Farm Bill removed hemp-derived products from Schedule I status under the Controlled Substances Act. However,...